Skip to main content

Advertisement

SpringerLink
Log in

Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

The role of HistoScanning™ (HS) in prostate biopsy is still indeterminate. Existing literature is sparse and controversial. To provide more evidence according to that important clinical topic, we analyzed institutional data from the Martini-Clinic, Prostate Cancer Center, Hamburg.

Methods

Patients who received prostate biopsy and who also received HS were included in the study cohort. A single examiner, blinded to pathological results, re-analyzed all HS data in accordance with sextants of the prostate. Each sextant was considered as an individual case. Corresponding results from biopsy and HS were analyzed. The area under the receiver-operating characteristic curve (AUC) for the prediction of a positive biopsy by HS was calculated. Furthermore, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were assessed according to different HS signal volume cutoffs (>0, >0.2 and >0.5 ml).

Results

Overall, 198 men were identified and 1,188 sextants were analyzed. The AUC to predict positive biopsy results by HS was 0.58. Sensitivity, specificity, PPV and NPV for HS to predict positive biopsy results per sextant, depending on different HS signal volume cutoffs (>0, >0.2 and >0.5 ml) were 84.1, 27.7, 29.5 and 82.9 %, 60.9, 50.6, 28.8 and 79.7 %, and 40.1, 73.3, 33.1 and 78.8 %, respectively.

Conclusions

Positive HS signals do not accurately predict positive prostate biopsy results according to sextant analysis. We cannot recommend a variation of well-established random biopsy patterns or reduction of biopsy cores in accordance with HS signals at the moment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61–71. doi:10.1016/j.eururo.2010.10.039

    Article  PubMed  Google Scholar 

  2. Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP III, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT (2010) NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Cancer Netw 8(2):240–262

    CAS  Google Scholar 

  3. Schroder FH, van den Bergh RC, Wolters T, van Leeuwen PJ, Bangma CH, van der Kwast TH, Roobol MJ (2010) Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies. Eur Urol 57(2):256–266. doi:10.1016/j.eururo.2009.10.031

    Article  PubMed  Google Scholar 

  4. Chun FK, Briganti A, Graefen M, Montorsi F, Porter C, Scattoni V, Gallina A, Walz J, Haese A, Steuber T, Erbersdobler A, Schlomm T, Ahyai SA, Currlin E, Valiquette L, Heinzer H, Rigatti P, Huland H, Karakiewicz PI (2007) Development and external validation of an extended 10-core biopsy nomogram. Eur Urol 52(2):436–444. doi:10.1016/j.eururo.2006.08.039

    Article  PubMed  Google Scholar 

  5. Benecchi L, Pieri AM, Melissari M, Potenzoni M, Pastizzaro CD (2008) A novel nomogram to predict the probability of prostate cancer on repeat biopsy. J Urol 180(1):146–149. doi:10.1016/j.juro.2008.03.043

    Article  PubMed  Google Scholar 

  6. Rochester MA, Pashayan N, Matthews F, Doble A, McLoughlin J (2009) Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population. BMC Urol 9:7. doi:10.1186/1471-2490-9-7

    Article  PubMed Central  PubMed  Google Scholar 

  7. Bul M, Zhu X, Valdagni R, Pickles T, Kakehi Y, Rannikko A, Bjartell A, van der Schoot DK, Cornel EB, Conti GN, Boeve ER, Staerman F, Vis-Maters JJ, Vergunst H, Jaspars JJ, Strolin P, van Muilekom E, Schroder FH, Bangma CH, Roobol MJ (2013) Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol 63(4):597–603. doi:10.1016/j.eururo.2012.11.005

    Article  PubMed  Google Scholar 

  8. Neill MG, Toi A, Lockwood GA, Evans A, Tammsalu L, Fleshner NE (2008) Systematic lateral prostate biopsy—are the benefits worth the costs? J Urol 179(4):1321–1326. doi:10.1016/j.juro.2007.11.065

    Article  PubMed  Google Scholar 

  9. Simmons LA, Autier P, Zat’ura F, Braeckman J, Peltier A, Romic I, Stenzl A, Treurnicht K, Walker T, Nir D, Moore CM, Emberton M (2012) Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(). BJU Int 110(1):28–35. doi:10.1111/j.1464-410X.2011.10734.x

    Article  PubMed  Google Scholar 

  10. Braeckman J, Autier P, Garbar C, Marichal MP, Soviany C, Nir R, Nir D, Michielsen D, Bleiberg H, Egevad L, Emberton M (2008) Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int 101(3):293–298. doi:10.1111/j.1464-410X.2007.07232.x

    Article  PubMed  Google Scholar 

  11. Braeckman J, Autier P, Soviany C, Nir R, Nir D, Michielsen D, Treurnicht K, Jarmulowicz M, Bleiberg H, Govindaraju S, Emberton M (2008) The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int 102(11):1560–1565. doi:10.1111/j.1464-410X.2008.07878.x

    Article  PubMed  Google Scholar 

  12. Salomon G, Spethmann J, Beckmann A, Autier P, Moore C, Durner L, Sandmann M, Haese A, Schlomm T, Michl U, Heinzer H, Graefen M, Steuber T (2013) Accuracy of HistoScanning for the prediction of a negative surgical margin in patients undergoing radical prostatectomy. BJU Int 111(1):60–66. doi:10.1111/j.1464-410X.2012.11396.x

    Article  PubMed  Google Scholar 

  13. Hamann MF, Hamann C, Schenk E, Al-Najar A, Naumann CM, Junemann KP (2013) Computer-aided (HistoScanning) biopsies versus conventional transrectal ultrasound-guided prostate biopsies: do targeted biopsy schemes improve the cancer detection rate? Urology 81(2):370–375. doi:10.1016/j.urology.2012.08.072

    Article  PubMed  Google Scholar 

  14. Nunez-Mora C, Garcia-Mediero JM, Patino P, Orellana C, Garrido A, Rojo A, Rendon D (2013) Utility of Histoscanning prior to prostate biopsy for the diagnosis of prostate adenocarcinoma. Actas Urol Esp. doi:10.1016/j.acuro.2013.01.003

    PubMed  Google Scholar 

  15. Macek P, Barret E, Sanchez-Salas R, Galiano M, Rozet F, Ahallal Y, Gaya JM, Durant M, Mascle L, Giedelman C, Lunelli L, Validire P, Nesvadba M, Cathelineau X (2013) Prostate Histoscanning in clinically localized biopsy proven prostate cancer: an accuracy study. J Endourol. doi:10.1089/end.2013.0419

    PubMed  Google Scholar 

  16. Schiffmann J, Fischer J, Tennstedt P, Beyer B, Bohm K, Michl U, Graefen M, Salomon G (2013) Comparison of prostate cancer volume measured by HistoScanning and final histopathological results. World J Urol. doi:10.1007/s00345-013-1211-3

    PubMed  Google Scholar 

  17. Javed SCE, Beveridge S, Bott S, Eden C, Langley S (2013) Does prostate HistoscanningTM accurately identify prostate cancer, measure tumour volume and assess pathological stage prior to radical prostatectomy? J Clin Urol. doi:10.1177/2051415813489682

    Google Scholar 

  18. Javed S, Chadwick E, Edwards AA, Beveridge S, Laing R, Bott S, Eden C, Langley S (2013) Does HistoScanning play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies. BJU Int. doi:10.1111/bju.12568

  19. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280(11):969–974

    Article  PubMed  Google Scholar 

  20. Salomon G, Schiffmann J (2014) Real-time elastography for the detection of prostate cancer. Curr Urol Rep 15(3):392. doi:10.1007/s11934-013-0392-z

    Article  PubMed  Google Scholar 

  21. Bjurlin MA, Meng X, Le Nobin J, Wysock JS, Lepor H, Rosenkrantz AB, Taneja SS (2014) Optimization of prostate biopsy: the role of MRI targeted biopsy in detection, localization, and risk assessment. J Urol. doi:10.1016/j.juro.2014.03.117

    Google Scholar 

  22. Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L, Taneja SS, Emberton M (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63(1):125–140. doi:10.1016/j.eururo.2012.06.004

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical standard

The study was approved by the local ethics committee of the Medical Board Hamburg (PV3848).

Author information

Authors and Affiliations

  1. Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    J. Schiffmann, P. Tennstedt, J. Fischer, B. Beyer, K. Boehm, U. Michl, M. Graefen & G. Salomon

  2. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, 264 Blvd. Rene-Levesque E. Room 228, Montreal, QC, H2X 1P1, Canada

    J. Schiffmann, Zhe Tian, M. Sun & G. Gandaglia

Authors
  1. J. Schiffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Tennstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhe Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Beyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Boehm
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Gandaglia
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. U. Michl
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Graefen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. G. Salomon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Schiffmann.

Additional information

J. Schiffmann and P. Tennstedt have contributed equally to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schiffmann, J., Tennstedt, P., Fischer, J. et al. Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate. World J Urol 32, 925–930 (2014). https://doi.org/10.1007/s00345-014-1330-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-014-1330-5

Keywords

Search

Navigation